Management of cardiac dysrhythmias following hydrocarbon abuse: Clinical toxicology teaching case from NACCT acute and intensive care symposium

References

• Bass, M. Sudden sniffing death. JAMA 1970; 212:2075–2079.
   PubMed Web of Science ®Google Scholar
• Bowen S. Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 2011; 46:68–72.
   PubMed Web of Science ®Google Scholar
• Cruz, S. The latest evidence in the neuroscience of solvent misuse: an article written for service providers. Subst Use Misuse 2011; 46:62–67.
   PubMed Web of Science ®Google Scholar
• Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Human Toxicol 1989; 8:287–292.
   PubMedGoogle Scholar
• Reinhardt CF, Azar A, Maxfield ME, Smith PE, Mullin LS. Cardiac arrhythmias and aerosol “Sniffing”. Arch Environ Health 1971; 22:265–279.
   PubMed Web of Science ®Google Scholar
• Adgey AAJ, Johnston PW, McMechan S. Sudden cardiac death and substance abuse. Resuscitation 1995; 29:219–221.
   PubMed Web of Science ®Google Scholar
• Mullin LS, Azar A, Reinhardt CF, Smith PE, Fabryka EF. Halogenated hydrocarbon-induced cardiac arrhythmias associated with release of endogenous epinephrine. Am Ind Hyg Assoc J 1972; 33:389–396.
   PubMed Web of Science ®Google Scholar
• Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 2011; 6:18–31.
   PubMedGoogle Scholar
• Himmel HM. Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?. Crit Rev Toxicol 2008; 38:773–803.
   PubMed Web of Science ®Google Scholar
• Alper AT, Akyol A, Hasdemir H, Nurkalem Z, Guler O, Guvenx TS, et al. Glue (Toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol 2008; 20:37–41.
   PubMed Web of Science ®Google Scholar
• Todd EP, Vick RL. The influence of plasma potassium concentration on hydrocarbon-epinephrine arrhythmia. Proc West Pharmacol Soc 1968; 11:112–113.
   PubMedGoogle Scholar
• Cruz SL, Orta-Salazar G, Gauthereau MY, Pena LMP, Salinas-Stefanon EM. Inhibition of cardiac sodium currents by toluene exposure. Br J Pharmaco 2003; 140:653–660.
   PubMed Web of Science ®Google Scholar
• Izumi Y, Okatani H, Shiota M, Nakao T, Ise R, Kito G, et al. Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates. Hypertens Res 2009; 32: 339–346.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Heinroth K, Richards D, Plews P, Toraason M. Depression of calcium dynamics in cardiac myocytes – a common mechanism of halogenated hydrocarbon anesthetics and solvents. J Mol Cell Cardio 1994; 26:579–589.
   PubMed Web of Science ®Google Scholar
• Garb S, Chenoweth M. Studies on hydrocarbon-epinephrine induced ventricular fibrillation. J. Pharmacol Exp Ther 1948; 94:12–18.
   PubMed Web of Science ®Google Scholar
• De Roock S, Beauloye C, De Bauwer I, Vancraynest D, Gurne O, Gerber B, Hantson P. Tako-tsubo syndrome following nortripyline overdose. Clin Toxicol 2008; 46:475–478.
   PubMed Web of Science ®Google Scholar
• Winogradow J, Geppert G, Reinhard W, Resch M, Radke PW, Hengstenberg C. Tako-tsubo cardiomyopathy after administration of intravenous epinephrine during an anaphylactic reaction. Int J Card 2011; 147:309–311.
   PubMed Web of Science ®Google Scholar
• Mendoza I, Novaro G. Repeat recurrence of takotsubo cardiomyopathy related to inhaled beta-2-adrenoceptor agonists. World J Card 2012; 4:211–213.
   PubMedGoogle Scholar
• Akashi Y, Nakazawa K, Sakakibara M, Miyake F, Sasaka K. Reversible left ventricular dysfunction “Takotsubo” cardiomyopathy related to catecholamine cardiotoxicty. J Electrocardiol 2002; 35: 351–356.
   PubMed Web of Science ®Google Scholar
• Edwards KE, Wenstone R. Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth 2000; 84:803–805.
   PubMed Web of Science ®Google Scholar
• Bailey B, Loebstein R, Lai C, McGuigan MA. Two cases of chlorinated hydrocarbon-associated myocardial ischemia. Vet Human Toxicology 1997; 39:298–301.
   PubMedGoogle Scholar
• Hantson P, Beauloye C. Myocardial metabolism in toxin-induced heart failure and therapeutic implications. Clin Toxicol 2012; 50:166–171.
   Web of Science ®Google Scholar
• Reynolds AK. Cardiac arrhythmias in sensitized hearts – primary mechanisms involved. Res Commun Chem Pathol Pharmacol 1983; 40:3–14.
   PubMedGoogle Scholar
• Vandam L. The hydrocarbon-epinephrine disturbance in man. Anesthesiology 1962; 21:388–390.
   Google Scholar
• Hatch N, Reyes B, Quan D. Successful resuscitation following sudden-sniffing death syndrome: a case report and review of the literature. Manuscript in preparation.
   Google Scholar
• Zahedi A, Grant MH, Wong DT. Successful treatment of chloral hydrate cardiac toxicity with propranolol. Am J Emerg Med 1999; 17:490–491.
   PubMed Web of Science ®Google Scholar
• Mortiz F, de La Chapelle A, Bauer F, Leroy JP, Goulie JP, Bonmarchand G. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning. Intensive Care Med 2000; 26:256.
   PubMed Web of Science ®Google Scholar
• Price K, Fligner D. Treatment of caffeine toxicity with esmolol. Ann Emerg Med 1990; 19:85–87.
   Google Scholar
• Maze M, Smith CM. Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology 1983; 59:322–326.
   PubMed Web of Science ®Google Scholar
• Senthilkumaran S, Meenakshisundaram R, Michaels AD, Balamurgan N, Thirumalaikolundusubramanian P. Ventricular fibrillation after exposure to air freshener-death just a breath away. J Electrocardiol 2012; 45:164–166.
   PubMed Web of Science ®Google Scholar
• Dimich I, Lingham R, Narang J, Sampson I, Shiang H. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs. Can J Anaesth 1992; 39:83–86.
   PubMed Web of Science ®Google Scholar
• Kaoukis A, Panagopoulou V, Mojibian H, Jacoby D. Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink. Circulation 2012; 125:1584–1585.
   PubMed Web of Science ®Google Scholar
• Asidawi S, Muth J, Wilkin J. Adderall induced inverted-Takotsubo cardiomyopathy. Cathet Cardiovasc Diagn 2011; 78:910–913.
   Google Scholar
• Nelson LS, Lewin NA, Howland M, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's Toxicologic Emergencies. 8th ed. New York: McGraw-Hill Lange, 2006:1234.
   Google Scholar
• Lin C, Lai S. Takotsubo cardiomyopathy related to carbamate and pyrethroid intoxication. Resuscitation 2010; 81:1051–1052.
   PubMed Web of Science ®Google Scholar
• Takada K, Sumikawa K, Kamibayashi T, Hayashi Y, Yamatodani A, Kawabata K, Yoshiya I. Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats. Anesthesiology 1993; 79:563–570.
   PubMed Web of Science ®Google Scholar